Product
PF-07062119
1 clinical trial
4 indications
Indication
Gastrointestinal TumorsIndication
Colorectal adenocarcinomaIndication
Gastric AdenocarcinomaIndication
Esophageal AdenocarcinomaClinical trial
A PHASE 1 DOSE ESCALATION AND EXPANSION STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS AND ANTI TUMOR ACTIVITY OF PF-07062119 IN PATIENTS WITH ADVANCED GASTROINTESTINAL TUMORSStatus: Terminated, Estimated PCD: 2023-11-28